Literature DB >> 28755849

Current antiviral drugs and their analysis in biological materials-Part I: Antivirals against respiratory and herpes viruses.

Lucie Nováková1, Jakub Pavlík2, Lucia Chrenková2, Ondřej Martinec3, Lukáš Červený3.   

Abstract

This review article is the first in the series providing an overview of currently used antiviral drugs and presenting contemporary approaches to their analysis. Large number of available antivirals and their structural variability makes this task very challenging. Trying to cover this topic comprehensively while maintaining reasonable size of the article, the review is presented in two parts. For the purpose of the overall review, antivirals were divided into four groups: (i) antivirals against herpes viruses, (ii) antivirals against respiratory viruses, (iii) antivirals against hepatitis viruses, and (iv) antivirals against HIV. Part one is devoted to the groups (i) and (ii) and also concerns the key features of the bioanalytical method. The mechanisms of action of antivirals against respiratory and herpes viruses and their use in clinical practice are briefly outlined, and the analytical methods for selected representatives of each class are described in more detail. The methods developed for the determination of drugs from these classes mostly include conventional procedures. In contrast, current trends such as UHPLC are used rarely and proper method validation based on requirements of bioanalytical guidelines can be often considered insufficient.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antivirals; Chromatography; HIV; Hepatitis viruses; Herpes viruses; Mass spectrometry; Respiratory viruses; Sample preparation

Mesh:

Substances:

Year:  2017        PMID: 28755849     DOI: 10.1016/j.jpba.2017.06.071

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.

Authors:  Ondrej Martinec; Martin Huliciak; Frantisek Staud; Filip Cecka; Ivan Vokral; Lukas Cerveny
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

2.  Antiretroviral Concentration in Hair as a Measure for Antiretroviral Medication Adherence: A Systematic Review of Global Literature.

Authors:  Quan Zhang; Shan Qiao; Xueying Yang; Xiaoming Li
Journal:  AIDS Behav       Date:  2020-01

3.  Determination of Antiviral Drugs and Their Metabolites Using Micro-Solid Phase Extraction and UHPLC-MS/MS in Reversed-Phase and Hydrophilic Interaction Chromatography Modes.

Authors:  Luboš Fical; Maria Khalikova; Hana Kočová Vlčková; Ivona Lhotská; Zuzana Hadysová; Ivan Vokřál; Lukáš Červený; František Švec; Lucie Nováková
Journal:  Molecules       Date:  2021-04-07       Impact factor: 4.411

4.  Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19).

Authors:  Simona De Vita; Maria Giovanna Chini; Gianluigi Lauro; Giuseppe Bifulco
Journal:  RSC Adv       Date:  2020-11-10       Impact factor: 4.036

Review 5.  Antiviral Activities of Oleanolic Acid and Its Analogues.

Authors:  Vuyolwethu Khwaza; Opeoluwa O Oyedeji; Blessing A Aderibigbe
Journal:  Molecules       Date:  2018-09-09       Impact factor: 4.411

6.  SARS-CoV-2: What do we know so far?

Authors:  Pratik H Khedkar; Andreas Patzak
Journal:  Acta Physiol (Oxf)       Date:  2020-04-11       Impact factor: 7.523

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.